← Leaderboards
Rhonda Szczesniak
Cincinnati Childrens Hosp Med Ctr
$5,247,990
Attributed
$5,642,363
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,642,363 · 4
By mechanism
R01$2,286,948 · 1
U2C$1,804,965 · 1
R61$788,746 · 1
K25$761,704 · 1
Top collaborators
- Assem G Ziady2 shared
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Marc E. Rothenberg$46,535,760
- Maurizio Macaluso$4,056,141
- Ronald Mark Payne$3,741,089
- James Cnota$9,943,565
- Eileen Catherine King$22,091,258
Others in their field
Top investigators on “Caring”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$305,871,236
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$279,179,778
- Chanza Baytop · Westat, Inc.$271,217,917
- Larry Arthur$256,720,406
Research focus
CaringFoundationsDesignCause Of DeathData AnalysesPreventLungCystic FibrosisLung DiseasesCystic Fibrosis PatientsAdolescenceDisease ProgressionAlgorithmsEnvironmentPhenotypeInnovationTranslatingLightBaseUnited States National Institutes Of HealthClinical PracticeDetectionEarly DiagnosisCystic Fibrosis Transmembrane Conductance Regulator
Grant awards (13)
Clinical Research Core$1,804,965
U2C · FY2025 · TR · contact PI
R01- Mapping environmental contributions to rapid lung disease progression in cystic fibrosis$451,819
R01 · FY2023 · HL · contact PI
R01- Mapping environmental contributions to rapid lung disease progression in cystic fibrosis$465,922
R01 · FY2022 · HL · contact PI
R01- Mapping environmental contributions to rapid lung disease progression in cystic fibrosis$470,453
R01 · FY2021 · HL · contact PI
Commercial Translation of Biomarker-based Platform for Personalized Forecasting of Rapid Lung Function Decline$397,500
R61 · FY2021 · HL
R01- Mapping environmental contributions to rapid lung disease progression in cystic fibrosis$442,678
R01 · FY2020 · HL · contact PI
Commercial Translation of Biomarker-based Platform for Personalized Forecasting of Rapid Lung Function Decline$391,246
R61 · FY2020 · HL
R01- Mapping environmental contributions to rapid lung disease progression in cystic fibrosis$456,076
R01 · FY2019 · HL · contact PI
Preventing rapid decline in CF: statistical research career commitment$123,652
K25 · FY2019 · HL · contact PI
Preventing rapid decline in CF: statistical research career commitment$162,306
K25 · FY2018 · HL · contact PI
Preventing rapid decline in CF: statistical research career commitment$169,473
K25 · FY2017 · HL · contact PI
Preventing rapid decline in CF: statistical research career commitment$160,686
K25 · FY2016 · HL · contact PI
Preventing rapid decline in CF: statistical research career commitment$145,587
K25 · FY2015 · HL · contact PI